Morgan Stanley Maintains Underweight on Adient, Lowers Price Target to $35
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Adam Jonas has maintained an Underweight rating on Adient (NYSE:ADNT) and reduced the price target from $38 to $35.
November 14, 2023 | 1:59 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley has maintained an Underweight rating on Adient and lowered the price target from $38 to $35, indicating a bearish outlook.
The reduction in price target by a major analyst like Morgan Stanley suggests a negative outlook on the stock's value, which could lead to a decrease in investor confidence and a potential drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100